Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1400+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
11202 Results
2581
Coronavirus disease 2019 and the impact on substance use disorder treatments
Type: Journal Article
Authors: Osnat C. Melamed, Wayne K. deRuiter, Leslie Buckley, Peter Selby
Year: 2022
Topic(s):
HIT & Telehealth See topic collection
,
Medically Unexplained Symptoms See topic collection
,
Opioids & Substance Use See topic collection
2582
Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women
Type: Journal Article
Authors: D. L. Bogen, B. H. Hanusa, J. M. Perel, F. Sherman, M. A. Mendelson, K. L. Wisner
Year: 2017
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
2583
Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women
Type: Journal Article
Authors: D. L. Bogen, B. H. Hanusa, J. M. Perel, F. Sherman, M. A. Mendelson, K. L. Wisner
Year: 2017
Publication Place: United States
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
2584
Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999-2015
Type: Journal Article
Authors: C. J. Ruhm
Year: 2018
Abstract: BACKGROUND AND AIMS: Most prior estimates of opioid-involved drug poisoning mortality counts or rates are understated because the specific drugs leading to death are frequently not identified on death certificates. This analysis provides corrected national estimates of opioid and heroin/synthetic opioid-involved counts and mortality rates, as well as changes over time in them from 1999 to 2015. METHODS: Data on drug poisoning deaths to US residents from 1999 to 2015, obtained from the Centers for Disease Control and Prevention (CDC) Multiple Cause of Death (MCOD) files, were used with the drugs involved in fatal overdoses imputed when not identified on the death certificates. RESULTS: The official CDC figure that 33?091 drug deaths involved opioids in 2015 is an undercount, with the actual number being approximately 39 999. Corrected counts and rates of any opioid and heroin/synthetic opioid-involved drug deaths are 20-35% higher in every year than reported figures. The corrections almost always raise the changes estimated to have occurred since 1999, with the largest differences observed in 2011 for any opioids (5677 deaths and 1.7 per 100?000) and in 2015 for heroin/synthetic opioids (3228 deaths and 1.0 per 100?000). However, percentage growth since 1999 is sometimes slower when based on corrected rather than reported fatality data, and with sensitivity to the choice of base years. CONCLUSIONS: Death certificate reports understate the prevalence of and changes over time in opioid and heroin/synthetic opioid-involved drug mortality in the United States. Adjustments imputing the drugs involved for cases where none are identified on the death certificates are likely to provide more accurate estimates.
Topic(s):
Opioids & Substance Use See topic collection
2585
Correction to: Payment strategies for behavioral health integration in hospital-affiliated and non-hospital-affiliated primary care practices
Type: Journal Article
Authors: indicated No authorship
Year: 2023
Topic(s):
Financing & Sustainability See topic collection
2586
Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail
Type: Journal Article
Authors: A. Bailey, R. Senthilkumar, E. A. Evans
Year: 2023
2587
Correlates of Pregnant Women's Participation in a Substance Use Assessment and Counseling Intervention Integrated into Prenatal Care
Type: Journal Article
Authors: K. C. Young-Wolff, L . Y. Tucker, M. A. Armstrong, A. Conway, C. Weisner, N. Goler
Year: 2020
Abstract:

INTRODUCTION: Screening and referral for substance use are essential components of prenatal care. However, little is known about barriers to participation in substance use interventions that are integrated within prenatal care. METHODS: Our study examines demographic and clinical correlates of participation in an initial assessment and counseling intervention integrated into prenatal care in a large healthcare system. The sample comprised Kaiser Permanente Northern California pregnant women with a live birth in 2014 or 2015 who screened positive for prenatal substance use via a self-reported questionnaire and/or urine toxicology test given as part of standard prenatal care (at ~ 8 weeks gestation). RESULTS: Of the 11,843 women who screened positive for prenatal substance use (median age = 30 years; 42% white; 38% screened positive for alcohol only, 20% for cannabis only, 5% nicotine only, 17% other drugs only, and 19% ≥ 2 substance categories), 9836 (83%) completed the initial substance use assessment and counseling intervention. Results from multivariable logistic regression analyses indicated that younger age, lower income, single marital status, and a positive urine toxicology test predicted higher odds of participation, while other/unknown race/ethnicity, greater parity, receiving the screening later in pregnancy, and screening positive for alcohol only or other drugs only predicted lower odds of participation (all Ps < .05). DISCUSSION: Findings suggest that integrated substance use interventions can successfully reach vulnerable populations of pregnant women (e.g., younger, lower income, racial/ethnic minorities). Future research should address whether differences in participation are due to patient (e.g., type of substance used, perceived stigma) or provider factors (e.g., working harder to engage traditionally underserved patients).

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
2588
Correlates of self-diagnosis of chronic medical and mental health conditions in under-served African American and Latino populations
Type: Journal Article
Authors: C. Ani, M. Bazargan, S. Bazargan-Hejazi, R. M. Andersen, D. W. Hindman, R. S. Baker
Year: 2008
Publication Place: United States
Abstract: OBJECTIVE: This study examines the correlates of self-diagnosis of chronic medical and mental health conditions in under-served minority populations. The Behavioral Model for Vulnerable Populations was employed to compare the predisposing and enabling characteristics of two groups: the first group consisted of individuals who self-reported their medical conditions without a presumptive or definitive physician diagnosis, while the second group consisted of individuals who self-reported their medical conditions with a presumptive or definitive physician diagnosis of their condition. STUDY SETTING: The sample consisted of 287 African American and Latino heads of household. This sample was obtained from a geographically defined random sample of 418 households from three urban public housing communities in Los Angeles County, California. STUDY DESIGN: This study was a cross-sectional, face-to-face, semistructured interview survey. RESULTS: Using logistic regression techniques and controlling for demographic characteristics, the results indicate that accessibility, affordability, continuity of medical care, and financial strains were the core concepts that explain the gap between self vs physician diagnosis of medical conditions. CONCLUSION: This study identifies unique characteristics of minority persons who claimed that their medical conditions had not been presented to or diagnosed by a medical provider in comparison to those who are formally diagnosed by medical providers. The study provides an entry point for further examination of correlates and sequels of self-diagnosis and its resultant effects on professional treatment-seeking in minority populations with certain medically important chronic conditions.
Topic(s):
Healthcare Disparities See topic collection
2589
Correlates of specialty substance use treatment among adults with opioid use disorders
Type: Journal Article
Authors: Eric Romo, Christine M. Ulbricht, Robin E. Clark, Kate L. Lapane
Year: 2018
Topic(s):
Opioids & Substance Use See topic collection
2590
Correlates of Treatment Retention Among Persons with Serious Mental Illness Receiving Integrated Care in a Community Mental Health Setting
Type: Journal Article
Authors: Catherine M. Lemieux, Katherine A. Thomas, Chrisann M. Newransky, Hebah Khalifa, Amber R. Hebert
Year: 2018
Publication Place: London
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
2591
Correlation of cytokines, BDNF levels, and memory function in patients with opioid use disorder undergoing methadone maintenance treatment
Type: Journal Article
Authors: T . Y. Wang, S . Y. Lee, Y. H. Chang, S. L. Chen, P. S. Chen, C. H. Chu, S . Y. Huang, N. S. Tzeng, I. H. Lee, K. C. Chen, Y. K. Yang, S. H. Chen, J. S. Hong, R. B. Lu
Year: 2018
Publication Place: Ireland
Topic(s):
Opioids & Substance Use See topic collection
2592
Correlation of warm handoffs versus electronic referrals and engagement with mental health services co-located in a pediatric primary care clinic
Type: Journal Article
Authors: Paridhi Anand, Ninad Desai
Year: 2023
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
2593
Correspondence with general practitioners.
Type: Journal Article
Authors: David Syfret, Beatrice Huang
Year: 2014
Topic(s):
Education & Workforce See topic collection
2594
Cost and quality impact of Intermountain's mental health integration program
Type: Journal Article
Authors: B. Reiss-Brennan, P. C. Briot, L. A. Savitz, W. Cannon, R. Staheli
Year: 2010
Publication Place: United States
Abstract: Most patients with mental health (MH) conditions, such as depression, receive care for their conditions from a primary care physician (PCP) in their health/medical home. Providing MH care, however, presents many challenges for the PCP, including (1) the difficulty of getting needed consultation from an MH specialist; (2) the time constraints of a busy PCP practice; (3) the complicated nature of recognizing depression, which may be described with only somatic complaints; (4) the barriers to reimbursement and compensation; and (5) associated medical and social comorbidities. Practice managers, emergency departments, and health plans are stretched to provide care for complex patients with unmet MH needs. At the same time, payment reform linked to accountable care organizations and/or episodic bundle payments, MH parity rules, and increasing MH costs to large employers and payers all highlight the critical need to identify high-quality, efficient, integrated MH care delivery practices. Over the past ten years, Intermountain Healthcare has developed a team-based approach-known as mental health integration (MHI)-for caring for these patients and their families. The team includes the PCPs and their staff, and they, in turn, are integrated with MH professionals, community resources, care management, and the patient and his or her family. The integration model goes far beyond co-location in its team-based approach; it is operationalized at the clinic, thereby improving both physician and staff satisfaction. Patients treated in MHI clinics also show improved satisfaction, lower costs, and better quality outcomes. The MHI program is financially sustainable in routinized clinics without subsidies. MHI is a successful approach to improving care for patients with MH conditions in primary care health homes.
Topic(s):
Education & Workforce See topic collection
,
Financing & Sustainability See topic collection
,
Medically Unexplained Symptoms See topic collection
,
Healthcare Policy See topic collection
2595
Cost Benefits of Investing Early In Substance Abuse Treatment
Type: Government Report
Authors: Office of National Drug Control Policy - Executive Office of the President
Year: 2012
Publication Place: Washington, D.C.
Topic(s):
Grey Literature See topic collection
,
Financing & Sustainability See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

Grey literature is comprised of materials that are not made available through traditional publishing avenues. Examples of grey literature in the Repository of the Academy for the Integration of Mental Health and Primary Care include: reports, dissertations, presentations, newsletters, and websites. This grey literature reference is included in the Repository in keeping with our mission to gather all sources of information on integration. Often the information from unpublished resources is limited and the risk of bias cannot be determined.

2596
Cost effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder
Type: Journal Article
Authors: Wayne J. Katon, Peter Roy-Byrne, Joan Russo, Deborah Cowley
Year: 2002
Publication Place: US: American Medical Assn
Topic(s):
Financing & Sustainability See topic collection
2597
Cost effectiveness of brief interventions for reducing alcohol consumption
Type: Journal Article
Authors: S. E. Wutzke, A. Shiell, M. K. Gomel, K. M. Conigrave
Year: 2001
Publication Place: England
Abstract: The direct costs and health effects of a primary-care-based brief intervention for hazardous alcohol consumption were examined. The total cost of the intervention was calculated from costs associated with: marketing the intervention programme; providing training and support in the use of the intervention materials; physician time required for providing brief advice for 'at-risk' drinkers. The effect of the intervention on health outcomes was expressed in terms of number of life years saved by preventing alcohol-related deaths. This was derived by combining estimates of the impact of the programme if it were implemented nationally with available evidence on the health effects of excess alcohol consumption. Results are based on international trial evidence showing the physical resources required by the intervention and its effectiveness combined with Australian price data. The costs associated with screening and brief advice using the current intervention programme range from Aus$19.14 to Aus$21.50. The marginal costs per additional life year saved were below Aus$1873. The robustness of the model used is supported by an extensive sensitivity analysis. In comparison with existing health promotion strategies the costs and effects of the current intervention are highly encouraging.
Topic(s):
Financing & Sustainability See topic collection
2599
Cost of Implementing an Evidence-Based Intervention to Support Safer Use of Antipsychotics in Youth
Type: Journal Article
Authors: L. J. Chavez, J. E. Richards, P. Fishman, K. Yeung, A. Renz, L. M. Quintana, S. Massimino, R. B. Penfold
Year: 2023
2600
Cost of Practice Transformation in Primary Care: Joining an Accountable Care Organization
Type: Journal Article
Authors: R. Hofler, J. Ortiz, B. Cote
Year: 2018
Publication Place: United States
Abstract: The purpose of this study is to examine the costs related to practice transformation from the perspective of primary care organizations transitioning to become participants in Accountable Care Organizations (ACOs). We pose two research questions: 1) Will a Rural Health Clinic that participates in an Accountable Care Organization see higher or lower cost per visit, and 2) If the cost per visit is higher or lower, how large will that difference be? We analyze administrative data from a panel of over 800 Rural Health Clinics for the period 2007 - 2013 using a treatment effects approach, where a clinic's participation in an ACO is viewed as a "treatment." Since the first year that an RHC could join an ACO was 2012 and our most recent year of complete data is 2013, we restricted our analysis of the impact of participation in an ACO to include only 2012 and 2013 data. The estimates of the average treatment effect on the treated (ATET) pertain to only those RHCs that joined ACOs. The results show that those 20 sample ACO RHCs experienced an average from $15.00 to $18.61 higher cost per visit than the matching non-ACO RHCs. At this very early stage of ACO development, our results must be considered very preliminary at best. Whatever conclusions we draw from these results are intended to merely suggest what might be found once many more RHCs join ACOs. The conclusions we draw from this early analysis can lay a foundation for more analysis after data are available when more RHCs join ACOs.
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection